This page shows the latest mantle cell lymphoma news and features for those working in and with pharma, biotech and healthcare.
Calquence is approved to treat a number of blood cancers and is indicated for use in adults with previously treated mantle cell lymphoma (MCL) as well as adults with chronic lymphocytic ... leukaemia (CLL) or small lymphocytic lymphoma (SLL).
resulted in objective clinical responses in 47% of patients with mantle cell lymphoma (MCL) and 80% of patients with diffuse large B-cell lymphoma (DLBCL). ... Pioneering work by VelosBio scientists has yielded VLS-101, which in early studies has
X19 in relapsed or refractory mantle cell lymphoma. ... Despite recent advances, patients with relapsed/refractory mantle cell lymphoma currently face a significant lack of effective treatment options once their disease no longer responds to currently
Kite is seeking approval for the CAR-T therapy for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (MCL) – according to the company, if KTE-X19 is ... Relapse rates in mantle cell lymphoma remain overwhelmingly high and
Failed to beat rival in rare white blood cell cancer. BeiGene’s BTK inhibitor Brukinsa was unable to beat rival Imbruvica from Johnson &Johnson/AbbVie in Waldenstrom’s macroglublinemia. . ... Brukinsa is BeiGene’s first drug to have been approved
clinical activity in non-Hodgkin’s lymphoma (NHL) and an impressive three out of six responders in an aggressive form of NHL called Richter’s transformation. ... also in early-stage testing and had phase 1 results on show at ASH in CLL and mantle
More from news
Approximately 5 fully matching, plus 65 partially matching documents found.
Similarly, high TMB is correlated with better response to immune checkpoint inhibitors, so is the presence of TIL or a T cell GEP. ... mantle cell lymphoma minimal as an example.
AstraZeneca launched five significant new medicines in 2017: immunotherapy Iminzi, Calquence for mantle cell lymphoma, Qtern in type 2 diabetes, Bevespi Aerosphere in COPD and Fasenra for severe asthma.
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...